RSA Study of Furlong Evolution With and Without Collar

December 28, 2023 updated by: Gunnar Flivik, Region Skane

Evaluation of the Furlong Evolution Uncemented Hip Prosthesis With Special Emphasize on the Use of Collared Design or Not. A Prospective, Randomized Study Evaluated by RadioStereometric Analysis (RSA) and DXA.

The aim of this study is to further investigate the clinical and radiological importance of design changes in cementless hip prosthesis. The investigators have earlier evaluated the classical Furlong HAC total hip prosthesis and a first design change Furlong Active. Now a further development, Furlong Evolution, is to be evaluated. This prosthesis, furthermore, comes with and without a collar, and the investigators are going to randomize between the two. The investigators hypothesize that the new design will be easier to implant and will present equal or less migration than the older designs which would imply a favourable outcome in the long term. The investigators further hypothesize that the collar play no major part for the long term migration and bone remodelling.

We will now do a 10 year follow up of the patients including RSA, DXA and PROMS

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Skåne
      • Lund, Skåne, Sweden, 221 85
        • Department of Orthopedics, Skåne University Hospital, Lund University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primary osteoarthritis of the hip necessitating primary hip replacement
  • A femur considered suitable for uncemented fixation of the stem
  • Biological age <75 years old at the inclusion time of the study.

Exclusion Criteria:

  • Rheumatoid arthritis
  • Malignant disease
  • Severe osteoporosis
  • Earlier fracture or operation in the hip to be operated on
  • Peroperative fracture
  • Ongoing corticosteroid (oral) or immunosuppressive medication
  • Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Stem collar
The stem has two versions, one with and one without a collar. This arm will have stems with a collar. The classical Furlong HAC had a collar.
Active Comparator: No Stem collar
The stem has two versions, one with and one without a collar. This arm will have stems without a collar. The classical Furlong HAC had a collar.
The stem has two versions, one with and one without a collar. The classical Furlong HAC had a collar.
Other Names:
  • Furlong Evolution with collar
  • Furlong Evolution without collar

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiostereometric Analysis (RSA)
Time Frame: The first postoperative day, 14 days, 3 months, 1, 2, 5 and 10 years
This will measure the change in migration (translation and rotation around the x-, y-, and z-axis of the hip) over time. The migration pattern the first 2 years can predict the long term outcome.
The first postoperative day, 14 days, 3 months, 1, 2, 5 and 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual-energy X-ray absorptiometry (DXA)
Time Frame: 14 days postoperatively and after 1, 5 and 10 years
This will measure the change in bone density around the prosthesis during the first important year. This will tell if there is a bone resorption around the stem or cup.
14 days postoperatively and after 1, 5 and 10 years
General health questionnaire
Time Frame: Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively
EuroQol (EQ-5D) - a standardized instrument for use as measure of general health outcome over time
Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively
Hip specific health questionnaire
Time Frame: Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively
Hip disability and Osteoarthritis Outcome Score (HOOS) - this is a hip specific questionnaire that will measure how the operation has affected the patients function and pain situation.
Preoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Gunnar Flivik, MD PhD, Dept of Orthopedics, Skane University Hospital, Lund University, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2012

Primary Completion (Actual)

July 1, 2013

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

July 1, 2013

First Submitted That Met QC Criteria

July 3, 2013

First Posted (Estimated)

July 10, 2013

Study Record Updates

Last Update Posted (Estimated)

January 1, 2024

Last Update Submitted That Met QC Criteria

December 28, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Furlong Evolution_EW

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Replacement in Osteoarthritis Patients

Clinical Trials on Stem collar

3
Subscribe